Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
Day One Biopharmaceuticals (DAWN) Ownership Overview
2.29% Insiders
17.09% Mutual Funds
25.92% Other Institutional Investors
12.89% ETFs
41.81% Public Companies and
Individual Investors
The ownership structure of Day One Biopharmaceuticals (DAWN) stock is a mix of institutional, retail, and individual investors. Approximately 55.90% of the company’s stock is owned by Institutional Investors, 2.29% is owned by Insiders, and 41.81% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $23849 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $469308 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $932000 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $1787790 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,755,577 | Institution | 5.57% | 122,651,346 | |
| 5,316,367 | Institution | 5.15% | 113,291,781 | |
| 4,645,182 | Institution | 4.50% | 98,988,828 | |
| 3,731,971 | Institution | 3.61% | 79,528,302 | |
| 3,723,131 | Institution | 3.60% | 79,339,922 | |
| 2,697,768 | Institution | 2.61% | 57,489,436 | |
| 2,419,890 | Institution | 2.34% | 51,567,856 | |
| 1,798,991 | Insider | 1.74% | 38,336,498 | |
| 1,556,390 | Institution | 1.51% | 33,166,671 | |
| 1,532,924 | Institution | 1.48% | 32,666,610 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,645,182 | Institution | 4.50% | 98,988,828 | |
| 2,419,890 | Institution | 2.34% | 51,567,856 | |
| 1,556,390 | Institution | 1.51% | 33,166,671 | |
| 1,532,924 | Institution | 1.48% | 32,666,610 | |
| 1,311,736 | Institution | 1.27% | 27,953,094 | |
| 818,778 | Institution | 0.79% | 17,448,159 | |
| 771,247 | Institution | 0.75% | 16,435,274 | |
| 632,651 | Institution | 0.61% | 13,481,793 | |
| 601,990 | Institution | 0.58% | 12,828,407 | |
| 598,529 | Institution | 0.58% | 12,754,653 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,673,841 | Institution | 2.59% | 56,979,552 | |
| 2,411,994 | Institution | 2.33% | 25,567,136 | |
| 1,942,381 | Institution | 1.88% | 41,392,139 | |
| 875,835 | Institution | 0.85% | 9,283,851 | |
| 798,317 | Institution | 0.77% | 8,462,160 | |
| 647,256 | Institution | 0.63% | 13,793,025 | |
| 561,461 | Institution | 0.54% | 5,951,487 | |
| 535,512 | Institution | 0.52% | 11,411,761 | |
| 388,862 | Institution | 0.38% | 4,121,937 | |
| 357,174 | Institution | 0.35% | 7,611,378 |
FAQ
Who Owns Day One Biopharmaceuticals (DAWN)?
According to the latest TipRanks data, approximately 25.92% of the company's stock is held by institutional investors, 2.29% is held by insiders, and 41.81% is held by retail investors.
What percentage of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 25.92% of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors.
What percentage of Day One Biopharmaceuticals (DAWN) stock is held by retail investors?
According to the latest TipRanks data, approximately 41.81% of Day One Biopharmaceuticals (DAWN) stock is held by retail investors.
Who owns the most shares of Day One Biopharmaceuticals (DAWN)?
Peter Kolchinsky owns the most shares of Day One Biopharmaceuticals (DAWN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.